| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/07/2006 | US20060276634 PEG-conjugated erythropoietin |
| 12/07/2006 | US20060276632 Acid soluble proteins from micellar casein |
| 12/07/2006 | US20060276631 Antibody against a mast cell surface antigen |
| 12/07/2006 | US20060276630 Method for detecting protein crystal, apparatus for detecting protein crystal and program for detecting protein crystal |
| 12/07/2006 | US20060276629 Purification and characterization of soluble human HLA proteins |
| 12/07/2006 | US20060276624 Preparation of T-1249 peptides using two fragments that are synthesized using a solid phase approach; excellent purity and yield |
| 12/07/2006 | US20060276622 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 12/07/2006 | US20060276621 Glycosylated specificity exchangers |
| 12/07/2006 | US20060276586 Peg-physiologically active polypeptide homodimer complex having prolonged in vivo half-life and process for the preparation thereof |
| 12/07/2006 | US20060276539 selective androgen receptor modulator (SARM); sexual dysfunction hypogonadism, sarcopenia, osteopenia, osteoporosis, an alteration in cognition and mood, depression, anemia, hair loss, obesity |
| 12/07/2006 | US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid |
| 12/07/2006 | US20060276427 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 12/07/2006 | US20060276426 Human peroxisome proliferator activated receptor gamma (PPARgamma) gene regulatory sequences and uses therefor |
| 12/07/2006 | US20060276411 Novel non-selective cation channel in neuronal cells and methods for treating brain swelling |
| 12/07/2006 | US20060276403 Agonist polypeptide of receptor for ZOT and zonulin |
| 12/07/2006 | US20060276399 Peptide antagonists of zonulin and methods for use of the same |
| 12/07/2006 | US20060276397 Crystallization of IGF-1 |
| 12/07/2006 | US20060276396 Stimulating insulin synthesis and release, enhancing adipose, muscle or liver tissue sensitivity towards insulin uptake, stimulating glucose uptake, slowing digestive process, or blocking the secretion of glucagon; glucagon-like protein |
| 12/07/2006 | US20060276392 Treatments employing neuronal exocytosis-inhibiting peptides |
| 12/07/2006 | US20060276387 Method of controlling transcription insulin gene |
| 12/07/2006 | US20060276384 Peptides and medicinal compositions containing the same |
| 12/07/2006 | US20060276383 Full length polynucleotide coding chicken type II collagen and the use of it |
| 12/07/2006 | US20060276382 Administering a natriuretic hormone peptide (NHP), or a nucleic acid sequence encoding NHP; respiratory system disorders |
| 12/07/2006 | US20060276379 Binding peptides specific for the extracellular domain of ErbB2 and uses therefor |
| 12/07/2006 | US20060276377 Factor VII or VIIa Polypeptide Variants |
| 12/07/2006 | US20060276375 Gpi anchored glycoprotein aca as a novel tumor marker |
| 12/07/2006 | US20060275898 Compositions and Methods for Making Embryonic Stem Cells |
| 12/07/2006 | US20060275897 Plasmid DNA or viral vector vaccine including components from different clades of Env and Gag-Pol-Nef from a single clade; multiclade HIV envelope immunogen |
| 12/07/2006 | US20060275884 For reducing unwanted proteolysis during purification of a target protein; for improving protein folding, solubility, and stability when the protein is produced in vivo and in vitro |
| 12/07/2006 | US20060275876 Use of selective labeling to detect and characterize molecular interactions by nuclear magnetic resonance spectroscopy |
| 12/07/2006 | US20060275872 Method for modifying transglutaminases from microorganisms |
| 12/07/2006 | US20060275871 encoding mammalian Ca2+/calmodulin stimulated phosphodiesterases (CaM-PDEs) and cyclic-GMP-stimulated phosphodiesterases (cGS-PDEs); drug screening to identify compounds which modulate the enzymatic activity of expression products |
| 12/07/2006 | US20060275870 Novel G-protein coupled receptors and uses therefor |
| 12/07/2006 | US20060275868 Fusion proteins comprising tumor necrosis factor receptor |
| 12/07/2006 | US20060275866 Novel nucleic acid sequences encoding G-protein coupled receptors |
| 12/07/2006 | US20060275865 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 12/07/2006 | US20060275864 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/07/2006 | US20060275856 Method for analyzing cell free notch cleavage and method for drug screening |
| 12/07/2006 | US20060275848 Diagnosis and treatment of microbacterial infections |
| 12/07/2006 | US20060275842 Methods and kits useful for the simplification of complex peptide mixtures |
| 12/07/2006 | US20060275839 Genes |
| 12/07/2006 | US20060275838 Compositions and methods for inhibiting liver stellate cell growth |
| 12/07/2006 | US20060275828 Use of a fluorescent protein for detecting interactions between a target protein and its ligand |
| 12/07/2006 | US20060275827 non-oligomerizing Clavularia teal fluorescent protein (TFP) variant having a tyrosine-derived chromophore; nucleic acid compatible with mammalian codon usage |
| 12/07/2006 | US20060275826 Artificial antibody comprising complementary peptide |
| 12/07/2006 | US20060275822 Fluorescent indicator using fret |
| 12/07/2006 | US20060275821 Method for isolating subpopulations of proteins that engage in protein-protein interactions |
| 12/07/2006 | US20060275819 Guanylate-binding protein |
| 12/07/2006 | US20060275803 Rat and mouse members of the CRISP family of genes |
| 12/07/2006 | US20060275796 Canine herpesvirus thymidine kinase nucleic acid molecules |
| 12/07/2006 | US20060275790 KCNQ5, a novel potassium channel |
| 12/07/2006 | US20060275768 Multiplex polymer ligation |
| 12/07/2006 | US20060275765 G-proteins |
| 12/07/2006 | US20060275758 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 12/07/2006 | US20060275755 Novel nucleic acids and polypeptides related to a guanine exchange factor of rho gtpase |
| 12/07/2006 | US20060275750 Bioreactive agents |
| 12/07/2006 | US20060275748 which promote strand transfer activity of viral integrase, such as HIV integrase; screening molecules for antiviral activity comprising exposing the molecules to epithelial growth factors, fragments or nucleotides codes and determining the ability to modulate the interaction with retroviral integrases |
| 12/07/2006 | US20060275746 Peptides which enhance transport across tissues and methods of identifying and using the same |
| 12/07/2006 | US20060275338 Intravascular prosthesis containing an inhibitor of smooth muscle cell proliferation such as fibulin-5 (UP50) and a growth factor such as vascular endothelial growth factor (VEGF); stents; restenosis |
| 12/07/2006 | US20060275330 Pygopus in diagnosis and treatment of cancer |
| 12/07/2006 | US20060275327 In vivo modulation of neuronal transport |
| 12/07/2006 | US20060275323 Particles of HCV envelope proteins: use for vaccination |
| 12/07/2006 | US20060275322 producing an immune response to hepatitis C virus infection; activating cytotoxic t lymphocytes in presence of major histocompatibility complex |
| 12/07/2006 | US20060275319 Saccharomyces cerevisiae yeast strain with functional expression of a GLUT transporter |
| 12/07/2006 | US20060275318 Surface protein of leptospira |
| 12/07/2006 | US20060275317 Vaccine compositions for prevention of chronic and infectious diseases |
| 12/07/2006 | US20060275316 Modulation of cxcr4 and related methods and compositions |
| 12/07/2006 | US20060275315 Nucleic acids and proteins from streptococcus groups a & b |
| 12/07/2006 | US20060275314 Transmembrane protein differentially expressed in cancer |
| 12/07/2006 | US20060275313 Therapeutic and diagnostic agents |
| 12/07/2006 | US20060275312 Molecule |
| 12/07/2006 | US20060275309 Peptide oligomers for use as hiv vaccines |
| 12/07/2006 | US20060275304 Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
| 12/07/2006 | US20060275302 a novel DNA, a carcinoma-associated gene comprising the DNA, a recombinant protein encoded by the DNA, an antibody binding to the protein, an anti-carcinoma agent comprising the antibody, a low-molecular-weight compound binding to the protein, a screening system |
| 12/07/2006 | US20060275301 Cell death-inducing agent |
| 12/07/2006 | US20060275299 Use of protein tyrosine phosphatase inhibitors for prevention and/or treatment of cancer |
| 12/07/2006 | US20060275297 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal |
| 12/07/2006 | US20060275293 Splice variant of the human pituitary growth hormone |
| 12/07/2006 | US20060275290 Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases |
| 12/07/2006 | US20060275287 Scroll compressor |
| 12/07/2006 | US20060275280 Contacting a latent myostatin complex comprising a myostatin pro peptide and a myostatin C-terminal fragment, and a metalloprotease that can cleave the myostatin pro peptide, with an agent that increases or decreases proteolytic cleavage of the pro peptide by the metalloprotease |
| 12/07/2006 | US20060275274 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome |
| 12/07/2006 | US20060275266 Tripeptide of FcyRIIA |
| 12/07/2006 | US20060275263 Cell proliferation inhibitory proteins and polynucleotides, antisense polynucleotides to the polynucleotides, cell proliferation inhibitors using the foregoing, cancer diagnostic agents, cancer therapeutic agents and compositions for gene therapy |
| 12/07/2006 | US20060275259 Il-8-like proteins |
| 12/07/2006 | US20060275258 Interferon-alpha induced gene |
| 12/07/2006 | US20060275257 G-CSF Conjugates |
| 12/07/2006 | US20060275256 Inhibition of pathogenic agents including alpha6beta1 integrin receptor of alpha6beta4 integrin receptor at a surface |
| 12/07/2006 | US20060275252 Moiety is positioned between a water-soluble polymer and a reactive group; water soluble polymer such as polyethylene glycol containing a urethane linkage moiety for example, and a reactive group for conjugating with biodrugs |
| 12/07/2006 | US20060275213 Tumor targeting agents and uses thereof |
| 12/07/2006 | US20060275211 Antibodies and related molecules that bind to 161P2F10B proteins |
| 12/07/2006 | DE10161899B4 Fusionsproteine gegen die Hodgkin-Krankheit Fusion proteins for Hodgkin's disease |
| 12/07/2006 | DE10161738B4 Fusionsproteine gegen T-Zell-Tumore Fusion proteins against T-cell tumors |
| 12/07/2006 | CA2611127A1 Mutant strains of lactic acid bacteria having a non-phosporylable lactose permease |
| 12/07/2006 | CA2610786A1 High affinity melan-a t cell receptors |
| 12/07/2006 | CA2610780A1 High-copy-number, high-expression vector having methionine aminopeptidase gene therein |
| 12/07/2006 | CA2610644A1 Rnai for control of insects and arachnids |
| 12/07/2006 | CA2610271A1 Autoactivated resistance protein |
| 12/07/2006 | CA2609951A1 Backbone cyclized melanocortin stimulating hormone (.alpha.s) analogs |
| 12/07/2006 | CA2609600A1 Tweak binding antibodies |